Trials / Conditions / Paraganglioma, Malignant

Paraganglioma, Malignant

4 registered clinical trials studyying Paraganglioma, Malignant.

Status	Trial	Sponsor	Phase
Unknown	The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic NCT05885399	Peking Union Medical College Hospital	Phase 2
Unknown	Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients NCT06015061	Peking Union Medical College Hospital	—
Completed	The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma NCT04860700	Peking Union Medical College Hospital	Phase 2
Completed	The Efficacy and Safety of Temozolomide in Patients With MPPGL NCT05858177	Peking Union Medical College Hospital	Phase 2